Ending DIR Fees Could Save Medicare Billions Tops SPT Week in Review


Top news of the week from Specialty Pharmacy Times.

5. It’s Not ‘Just A Uterine Fibroid’

In part 1 of 2, Beth Wallace shares her journey leading up to her diagnosis with leiomyosarcoma. Read more…

4. Rapid Hepatitis C Testing Improves Quality of Life Among Young Adults

Same-day results increase the number of individuals who get tested and treated for HCV. Read more…

3. FDA Approves Abemaciclib for Advanced, Metastatic Breast Cancer

Verzenio can be administered as a stand-alone treatment to patients previously treated with endocrine therapy and chemotherapy. Read more…

2. Humira Litigation Comes to a Close, Clearing Path to Biosimilar Launch

AbbVie grants commercialization rights to Amjevita. Read more…

1. Study: Ending DIR Fees Could Save Medicare Billions

The Improving Transparency and Accuracy in Medicare Part D Spending Act would end direct and indirect remuneration fees. Read more…

Related Videos
pharmacy oncology, Image Credit: © Konstantin Yuganov - stock.adobe.com
Pharmacist holding medicine box in pharmacy drugstore. | Image Credit: I Viewfinder - stock.adobe.com
Pharmacy Drugstore Checkout Cashier Counter | Image Credit: Gorodenkoff - stock.adobe.com
Mayo Clinic oncology pharmacy
Video 4 - "Applying NCCN Guidelines in the Treatment of mBC"
Therapy session -- Image credit: pressmaster | stock.adobe.com
Video 2 - "Highlighting the Available CDK4/6 Inhibitors"
Video - "Evaluating the Impact of Metastatic Breast Cancer on Patients"
© 2024 MJH Life Sciences

All rights reserved.